Zoetis (ZTS) Change in Receivables (2014 - 2026)
Zoetis (ZTS) posted quarterly Change in Receivables of $106.0 million for Q1 2026, up 130.43% year-over-year from $46.0 million in Q1 2025, and up 103.85% quarter-over-quarter from $52.0 million in Q4 2025.
Zoetis (ZTS) Change in Receivables (2014 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Change in Receivables for 13 consecutive years, with $106.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Receivables rose 130.43% year-over-year to $106.0 million; the TTM figure through Mar 2026 stood at $296.0 million (up 211.58% YoY), while the FY2025 annual figure was $236.0 million, up 286.89% from the prior year.
- Change in Receivables improved to $106.0 million in Q1 2026 per ZTS's latest filing, from $52.0 million in the prior quarter.
- Across five years, Change in Receivables topped out at $148.0 million in Q2 2025 and bottomed at -$73.0 million in Q4 2024.
- Historically, Change in Receivables has averaged $37.8 million across 5 years, with a median of $46.0 million in 2025.
- Annual changes were most pronounced in 2022 — Change in Receivables tumbled 933.33% — and 2025, when it surged 283.33%.
- Zoetis' Change in Receivables stood at $17.0 million in 2022, then soared by 182.35% to $48.0 million in 2023, then sank by 252.08% to -$73.0 million in 2024, then jumped by 171.23% to $52.0 million in 2025, then jumped by 103.85% to $106.0 million in 2026.
- Business Quant data shows ZTS's Change in Receivables at $106.0 million in Q1 2026, $52.0 million in Q4 2025, and -$10.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | 91.00 Mn |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | 66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | -445.26 Mn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | -1.70 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | 126.50 Mn |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 84.30 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Alkermes | 8.19 Bn | 7.53 Bn | 397.90 Mn | 48.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 66.00 Mn |
| Jun 30, 2026 | 66.00 Mn |
| Mar 31, 2026 | 106.00 Mn |
| Mar 31, 2026 | 106.00 Mn |
| Dec 31, 2025 | 52.00 Mn |
| Dec 31, 2025 | 52.00 Mn |
| Sep 30, 2025 | -10.00 Mn |
| Sep 30, 2025 | -10.00 Mn |
| Jun 30, 2025 | 148.00 Mn |
| Jun 30, 2025 | 148.00 Mn |
| Mar 31, 2025 | 46.00 Mn |
| Mar 31, 2025 | 46.00 Mn |
| Dec 31, 2024 | -73.00 Mn |
| Dec 31, 2024 | -73.00 Mn |
| Sep 30, 2024 | 22.00 Mn |
| Sep 30, 2024 | 22.00 Mn |
| Jun 30, 2024 | 100.00 Mn |
| Jun 30, 2024 | 100.00 Mn |
| Mar 31, 2024 | 12.00 Mn |
| Mar 31, 2024 | 12.00 Mn |